Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
The initiation and prevention of multiple sclerosis.
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature.
Innovation at RUSH
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
A controlled trial of natalizumab for relapsing multiple sclerosis.
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
MYRAC Rx
Neuromyelitis optica with very late onset.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
The olfactory vector hypothesis of neurodegenerative disease: is it viable?
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
MS and NMO: Partners No More.
Depakote: No Prescription Cheap Low
Pages
« first
‹ previous
…
166
167
168
169
170
171
172
173
174
…
next ›
last »